Investor's Business Daily on MSN
GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short
GSKGSK stock crumbled Friday after the Food and Drug Administration granted its blood cancer treatment, Blenrep, a ...
GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...
GSK plc (NYSE:GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback